OIS@AAO INDUSTRY CONSOLIDATION
Jim Mazzo Chairman & CEO -‐ AcuFocus October 16, 2014
UNKNOWN
THE
GOOD BAD TH
E
& T
HE
Impact of Consolida@on on Innova@on
Poten3al for greater resource alloca3on to disrup3ve innova3ons
Synergis3c benefits of combined core R&D competencies
Larger commercializa3on network to speed new innova3ons to market
Disrup3on of innova3on cycle and shiIs in priori3es
Loss of ins3tu3onal knowledge & exper3se
Reduced R&D spending; increased compe33on for clinical & regulatory resources
Are physicians & pa3ents beLer served over the long-‐term? How do changes in the compe33ve landscape affect the industry? Can merged company’s innova3on engine truly be more efficient and prolific?
THE BAD THE GOOD
THE UNKNOWN